Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors

Cell Transplantation

Volumn 18, Issue 7, 2009, Pages 804-814

  Glavaski Joksimovic, Aleksandra ^a   Virag, Tamas ^a,c   Chang, Qin A ^a   West, Neva C ^a   Mangatu, Thomas A ^a   McGrogan, Michael P ^b   Dugich Djordjevic, Millicent ^b,d   Bohn, Martha C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SanBio Inc   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d Neurocore   (United States)

Author keywords

6 OHDA; c Fos; Dopamine; Human mesenchymal stem cells; Neuroprotection; Nigrostriatal system; Notch1; Parkinson's disease

Indexed keywords

AMPHETAMINE; CYCLOSPORIN; DOPAMINE; NOTCH1 RECEPTOR; NUCLEAR MATRIX PROTEIN; OXIDOPAMINE; PROTEIN C FOS; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL MODEL; ARTICLE; BONE MARROW; CELL ISOLATION; CELL NUCLEUS; CELL SURVIVAL; CELL SUSPENSION; CELL THERAPY; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HOST; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INJECTION; MALE; MESENCHYMAL STEM CELL; NERVE DEGENERATION; NERVE FIBER; NEURAL STEM CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ONCOGENE C FOS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION; RAT; RECEPTOR UPREGULATION; REJUVENATION; SOMATIC CELL; STEREOTAXIS; ANIMAL; BONE MARROW CELL; CELL COMMUNICATION; CELL LINE; CYTOLOGY; DISEASE MODEL; FISCHER 344 RAT; MESENCEPHALON; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; NEOSTRIATUM; NERVE CELL; PARKINSONISM; PATHOLOGY; PHYSIOLOGY; SUBSTANTIA NIGRA;

PARKINSONIA; RATTUS;

AMPHETAMINE; ANIMALS; BONE MARROW CELLS; CELL COMMUNICATION; CELL LINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; HUMANS; MALE; MESENCEPHALON; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOSTRIATUM; NERVE DEGENERATION; NERVE FIBERS; NEURONS; PARKINSONIAN DISORDERS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, INBRED F344; SEROTONIN; SUBSTANTIA NIGRA; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

EID: 70350686405     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909X470801     Document Type: Article

References (75)

1. Akerud, P.; Holm, P. C.; Castelo-Branco, G.; Sousa, K.; Rodriguez, F. J.; Arenas, E. Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease. Mol. Cell. Neurosci. 21(2):205-222; 2002.
2. Akiyama, Y.; Radtke, C.; Kocsis, J. D. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J. Neurosci. 22(15):6623-6630; 2002.
3. Alexanian, A. R.; Maiman, D. J.; Kurpad, S. N.; Gennarelli, T. A. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment. Stem Cells Dev. 17(6):1123-1130; 2008.
4. Al-Khaldi, A.; Al-Sabti, H.; Galipeau, J.; Lachapelle, K. Therapeutic angiogenesis using autologous bone marrow stromal cells: Improved blood flow in a chronic limb ischemia model. Ann. Thorac. Surg. 75(1):204-209; 2003.
5. Al-Khaldi, A.; Eliopoulos, N.; Martineau, D.; Lejeune, L.; Lachapelle, K.; Galipeau, J. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Ther. 10(8):621-629; 2003. (Pubitemid 36553607)
6. Bankiewicz, K.; Mandel, R. J.; Sofroniew, M. V. Trophism, transplantation, and animal models of Parkinson's disease. Exp. Neurol. 124(1):140-149; 1993.
7. Bankiewicz, K. S.; Palmatier, M.; Plunkett, R. J.; Cummins, A.; Oldfield, E. H. Reversal of hemiparkinsonian syndrome in nonhuman primates by amnion implantation into caudate nucleus. J. Neurosurg. 81(6):869-876; 1994.
8. Beck, K. D.; Valverde, J.; Alexi, T.; Poulsen, K.; Moffat, B.; Vandlen, R. A.; Rosenthal, A.; Hefti, F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373(6512):339-341; 1995.
9. Behrstock, S.; Ebert, A.; McHugh, J.; Vosberg, S.; Moore, J.; Schneider, B.; Capowski, E.; Hei, D.; Kordower, J.; Aebischer, P.; Svendsen, C. N. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther. 13(5): 379-388; 2006.
10. Bendfeldt, K.; Radojevic, V.; Kapfhammer, J.; Nitsch, C. Basic fibroblast growth factor modulates density of blood vessels and preserves tight junctions in organotypic cortical cultures of mice: A new in vitro model of the blood-brain barrier. J. Neurosci. 27(12):3260-3267; 2007. (Pubitemid 46474137)
11. Bohn, M. C.; Cupit, L.; Marciano, F.; Gash, D. M. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237(4817):913-916; 1987.
12. Borlongan, C. V.; Lind, J. G.; Dillon-Carter, O.; Yu, G.; Hadman, M.; Cheng, C.; Carroll, J.; Hess, D. C. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res. 1010(1-2):108-116; 2004.
13. Bouchez, G.; Sensebe, L.; Vourc'h, P.; Garreau, L.; Bodard, S.; Rico, A.; Guilloteau, D.; Charbord, P.; Besnard, J. C.; Chalon, S. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem. Int. 52(7):1332-1342; 2008.
14. Caplan, A. I.; Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98(5):1076-1084; 2006.
15. Carbonetto, S. T.; Gruver, M. M.; Turner, D. C. Nerve fiber growth on defined hydrogel substrates. Science 216(4548):897-899; 1982.
16. Chen, J.; Li, Y.; Zhang, R.; Katakowski, M.; Gautam, S. C.; Xu, Y.; Lu, M.; Zhang, Z.; Chopp, M. Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res. 1005(1-2):21-28; 2004. (Pubitemid 38388396)
17. Chen, J.; Zhang, Z. G.; Li, Y.; Wang, L.; Xu, Y. X.; Gautam, S. C.; Lu, M.; Zhu, Z.; Chopp, M. Intravenous administration of human bone marrow stromal cells induces angio-genesis in the ischemic boundary zone after stroke in rats. Circ. Res. 92(6):692-699; 2003.
18. Chen, X.; Katakowski, M.; Li, Y.; Lu, D.; Wang, L.; Zhang, L.; Chen, J.; Xu, Y.; Gautam, S.; Mahmood, A.; Chopp, M. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: Growth factor production. J. Neurosci. Res. 69(5):687-691; 2002.
19. Choi-Lundberg, D. L.; Lin, Q.; Chang, Y. N.; Chiang, Y. L.; Hay, C. M.; Mohajeri, H.; Davidson, B. L.; Bohn, M. C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275(5301):838-841; 1997.
20. Choong, P. F.; Mok, P. L.; Cheong, S. K.; Leong, C. F.; Then, K. Y. Generating neuron-like cells from BM-derived mesenchymal stromal cells in vitro. Cytotherapy 9(2): 170-183; 2007.
21. Chopp, M.; Li, Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol. 1(2):92-100; 2002. (Pubitemid 37163494)
22. Cizkova, D.; Rosocha, J.; Vanicky, I.; Jergova, S.; Cizek, M. Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell. Mol. Neurobiol. 26(7-8):1167-1180; 2006.
23. Connor, B.; Kozlowski, D. A.; Schallert, T.; Tillerson, J. L.; Davidson, B. L.; Bohn, M. C. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged parkinsonian rat. Gene Ther. 6(12):1936-1951; 1999.
24. Crigler, L.; Robey, R. C.; Asawachaicharn, A.; Gaupp, D.; Phinney, D. G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol. 198(1):54-64; 2006.
25. Dezawa, M. Insights into autotransplantation: The unexpected discovery of specific induction systems in bone marrow stromal cells. Cell. Mol. Life Sci. 63(23):2764-2772; 2006.
26. Dezawa, M.; Kanno, H.; Hoshino, M.; Cho, H.; Matsumoto, N.; Itokazu, Y.; Tajima, N.; Yamada, H.; Sawada, H.; Ishikawa, H.; Mimura, T.; Kitada, M.; Suzuki, Y.; Ide, C. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. 113(12):1701-1710; 2004.
27. Dezawa, M.; Takahashi, I.; Esaki, M.; Takano, M.; Sawada, H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur. J. Neurosci. 14(11):1771-1776; 2001.
28. Dunnett, S. B.; Hernandez, T. D.; Summerfield, A.; Jones, G. H.; Arbuthnott, G. Graft-derived recovery from 6-OHDA lesions: Specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 71(2):411-424; 1988.
29. Ebert, A. D.; Beres, A. J.; Barber, A. E.; Svendsen, C. N. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp. Neurol. 209(1):213-223; 2008.
30. Gasmi, M.; Herzog, C. D.; Brandon, E. P.; Cunningham, J. J.; Ramirez, G. A.; Ketchum, E. T.; Bartus, R. T. Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease. Mol. Ther. 15(1):62-68; 2007.
31. Graybiel, A. M.; Moratalla, R.; Robertson, H. A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87(17):6912-6916; 1990.
32. Halliday, G. M.; Blumbergs, P. C.; Cotton, R. G.; Blessing, W. W.; Geffen, L. B. Loss of brainstem serotoninand substance P-containing neurons in Parkinson's disease. Brain Res. 510(1):104-107; 1990.
33. Hofstetter, C. P.; Schwarz, E. J.; Hess, D.; Widenfalk, J.; El Manira, A.; Prockop, D. J.; Olson, L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. USA 99(4): 2199-2204; 2002.
34. Horita, Y.; Honmou, O.; Harada, K.; Houkin, K.; Hamada, H.; Kocsis, J. D. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J. Neurosci. Res. 84(7):1495-1504; 2006.
35. Iravani, M. M.; Jackson, M. J.; Kuoppamaki, M.; Smith, L. A.; Jenner, P. 3,4-Methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated primates. J. Neurosci. 23(27):9107-9115; 2003.
36. Ishida, Y.; Hashiguchi, H.; Todaka, K.; Kuwahara, I.; Ishizuka, Y.; Nakane, H.; Uchimura, D.; Nishimori, T.; Mitsuyama, Y. Serotonergic activity in the rat striatum after intrastriatal transplantation of fetal nigra as measured by microdialysis. Brain Res. 788(1-2):207-214; 1998. (Pubitemid 28202163)
37. Jiang, Y.; Jahagirdar, B. N.; Reinhardt, R. L.; Schwartz, R. E.; Keene, C. D.; Ortiz-Gonzalez, X. R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W. C.; Largaespada, D. A.; Verfaillie, C. M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41-49; 2002.
38. Kim, J. H.; Auerbach, J. M.; Rodriguez-Gomez, J. A.; Velasco, I.; Gavin, D.; Lumelsky, N.; Lee, S. H.; Nguyen, J.; Sanchez-Pernaute, R.; Bankiewicz, K.; McKay, R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418(6893):50-56; 2002. (Pubitemid 34742566)
39. Kopen, G. C.; Prockop, D. J.; Phinney, D. G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. USA 96(19):10711-10716; 1999.
40. Kordower, J. H.; Aebischer, P. Gene therapy to the rescue in Parkinson's disease. Response from Kordower and Aebischer. Trends Pharmacol. Sci. 22(3):105-106; 2001.
41. Kordower, J. H.; Emborg, M. E.; Bloch, J.; Ma, S. Y.; Chu, Y.; Leventhal, L.; McBride, J.; Chen, E. Y.; Palfi, S.; Roitberg, B. Z.; Brown, W. D.; Holden, J. E.; Pyzalski, R.; Taylor, M. D.; Carvey, P.; Ling, Z.; Trono, D.; Hantraye, P.; Deglon, N.; Aebischer, P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290(5492):767-773; 2000.
42. Kordower, J. H.; Freeman, T. B.; Chen, E. Y.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Snow, B.; Olanow, C. W. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 13(3):383-393; 1998.
43. Kozlowski, D. A.; Connor, B.; Tillerson, J. L.; Schallert, T.; Bohn, M. C. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Exp. Neurol. 166(1): 1-15; 2000.
44. Letourneau, P. C.; Condic, M. L.; Snow, D. M. Interactions of developing neurons with the extracellular matrix. J. Neurosci. 14(3 Pt. 1):915-928; 1994.
45. Li, Y.; Chen, J.; Chen, X. G.; Wang, L.; Gautam, S. C.; Xu, Y. X.; Katakowski, M.; Zhang, L. J.; Lu, M.; Janakiraman, N.; Chopp, M. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery. Neurology 59(4):514-523; 2002. (Pubitemid 34919983)
46. Li, Y.; Chen, J.; Wang, L.; Zhang, L.; Lu, M.; Chopp, M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson's disease. Neurosci. Lett. 316(2):67-70; 2001.
47. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavii, B.; Frackowiak, R.; Leenders, K. L.; Sawle, G.; Rothwell, J. C.; Marsden, C. D.; Björklund, A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247(4942):574-577; 1990.
48. Mahmood, A.; Lu, D.; Chopp, M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery 55(5): 1185-1193; 2004. (Pubitemid 39525223)
49. Mahmood, A.; Lu, D.; Wang, L.; Chopp, M. Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J. Neurotrauma 19(12):1609-1617; 2002. (Pubitemid 36026216)
50. Muraoka, K.; Shingo, T.; Yasuhara, T.; Kameda, M.; Yuen, W. J.; Uozumi, T.; Matsui, T.; Miyoshi, Y.; Date, I. Comparison of the therapeutic potential of adult and embryonic neural precursor cells in a rat model of Parkinson disease. J. Neurosurg. 108(1):149-159; 2008.
51. Palmer, T. D.; Willhoite, A. R.; Gage, F. H. Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol. 425(4):479-494; 2000.
52. Pardridge, W. M.; Boado, R. J.; Farrell, C. R. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J. Biol. Chem. 265(29): 18035-18040; 1990.
53. Park, H. J.; Lee, P. H.; Bang, O. Y.; Lee, G.; Ahn, Y. H. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J. Neurochem. 107(1):141-151; 2008.
54. Pisati, F.; Bossolasco, P.; Meregalli, M.; Cova, L.; Belicchi, M.; Gavina, M.; Marchesi, C.; Calzarossa, C.; Soligo, D.; Lambertenghi-Deliliers, G.; Bresolin, N.; Silani, V.; Torrente, Y.; Polli, E. Induction of neurotrophin expression via human adult mesenchymal stem cells: Implication for cell therapy in neurodegenerative diseases. Cell Transplant. 16(1):41-55; 2007. (Pubitemid 46516657)
55. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147; 1999.
56. Prockop, D. J. Further proof of the plasticity of adult stem cells and their role in tissue repair. J. Cell Biol. 160(6): 807-809; 2003.
57. Roy, N. S.; Cleren, C.; Singh, S. K.; Yang, L.; Beal, M. F.; Goldman, S. A. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12(11):1259-1268; 2006.
58. Sakurada, K.; Ohshima-Sakurada, M.; Palmer, T. D.; Gage, F. H. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126(18):4017-4026; 1999.
59. Sanchez-Ramos, J. R. Neural cells derived from adult bone marrow and umbilical cord blood. J. Neurosci. Res. 69(6):880-893; 2002.
60. Sandyk, R.; Fisher, H. Serotonin in involuntary movement disorders. Int. J. Neurosci. 42(3-4):185-208; 1988.
61. Sauer, H.; Oertel, W. H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59(2):401-415; 1994.
62. Shih, C. C.; Fu, L.; Zhu, L.; Huang, Y.; Lee, T. D.; Forman, S. J. Derivation of neural stem cells from mesenchymal stem cells: Evidence for a bipotential stem cell population. Stem Cells Dev. 17(6):1109-1121; 2008.
63. Shintani, A.; Nakao, N.; Kakishita, K.; Itakura, T. Protection of dopamine neurons by bone marrow stromal cells. Brain Res. 1186:48-55; 2007.
64. Spina, M. B.; Squinto, S. P.; Miller, J.; Lindsay, R. M.; Hyman, C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and Nmethyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system. J. Neurochem. 59(1):99-106; 1992.
65. Takeuchi, Y.; Sawada, T.; Blunt, S.; Jenner, P.; Marsden, C. D. Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats. Brain Res. 562(2):301-305; 1991.
66. Takeuchi, Y.; Sawada, T.; Blunt, S.; Jenner, P.; Marsden, C. D. Serotonergic sprouting in the neostriatum after intrastriatal transplantation of fetal ventral mesencephalon. Brain Res. 551(1-2):171-177; 1991.
67. Tang, Y.; Yasuhara, T.; Hara, K.; Matsukawa, N.; Maki, M.; Yu, G.; Xu, L.; Hess, D. C.; Borlongan, C. V. Transplantation of bone marrow-derived stem cells: A promising therapy for stroke. Cell Transplant. 16(2):159-169; 2007.
68. Teng, H.; Zhang, Z. G.; Wang, L.; Zhang, R. L.; Zhang, L.; Morris, D.; Gregg, S. R.; Wu, Z.; Jiang, A.; Lu, M.; Zlokovic, B. V.; Chopp, M. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J. Cereb. Blood Flow Metab. 28(4):764-771; 2008.
69. Timmer, M.; Cesnulevicius, K.; Winkler, C.; Kolb, J.; Lipokatic-Takacs, E.; Jungnickel, J.; Grothe, C. Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion. J. Neurosci. 27(3):459-471; 2007. (Pubitemid 46143751)
70. Verfaillie, C. M. Adult stem cells: Assessing the case for pluripotency. Trends Cell Biol. 12(11):502-508; 2002.
71. Woodbury, D.; Schwarz, E. J.; Prockop, D. J.; Black, I. B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61(4):364-370; 2000.
72. Yang, M.; Donaldson, A. E.; Marshall, C. E.; Shen, J.; Iacovitti, L. Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo. Cell Transplant. 13(5):535-547; 2004. (Pubitemid 39557433)
73. Yasuhara, T.; Matsukawa, N.; Hara, K.; Yu, G.; Xu, L.; Maki, M.; Kim, S. U.; Borlongan, C. V. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J. Neurosci. 26(48):12497-12511; 2006.
74. Yoshii, S.; Oka, M. Peripheral nerve regeneration along collagen filaments. Brain Res. 888(1):158-162; 2001. (Pubitemid 32056272)
75. Zhao, L. R.; Duan, W. M.; Reyes, M.; Keene, C. D.; Verfaillie, C. M.; Low, W. C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174(1):11-20; 2002.